Bayer raises forecasts for 2014 after strong Q3

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said Thursday that it is raising its full-year profit targets after a strong third quarter.

"The strong upward trend in the life science businesses—healthcase and crop science—persisted in the third quarter," said chief executive Marijn Dekkers.

"We saw robust sales growth for our recently launched and in our crop science business in North and Latin America," Dekkers said.

"In view of the strong operational performance and including the consumer care business acquired from Merck and the current currency assumptions, Bayer raised its guidance for 2014."

In the three months to September alone, Bayer booked of 826 million euros ($1.04 billion), an increase of 12.7 percent over the year-earlier figure.

Operating profit also increased by 12.7 percent to 1.376 billion euros on a 5.6-percent rise in revenues to 10.187 billion euros, Bayer said.

Explore further

Bayer says new products push profits higher in Q3

© 2014 AFP

Citation: Bayer raises forecasts for 2014 after strong Q3 (2014, October 30) retrieved 22 August 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more